Chester County News and Community Website
WASHINGTON, D.C. — The Department of the Interior has opened a 60-day public comment period on proposed recreational climbing guidance and potential revisions to wilderness management policies, a review that …
Interior Seeks Public Input on Climbing, Wilderness Policies Read More
WASHINGTON, D.C. — The U.S. Department of the Interior is distributing more than $461 million in grants to states, territories, and the District of Columbia for parks, trails, and outdoor …
Interior Department Distributes $461 Million for Parks and Recreation Projects Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has cleared the first over-the-counter continuous glucose monitor for children, expanding access to glucose-tracking technology as rates of prediabetes and Type …
FDA Expands OTC Glucose Monitor Access to Children Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has authorized bemotrizinol for use in over-the-counter sunscreens, clearing the first new sunscreen active ingredient for the U.S. market in more …
FDA Adds First New Sunscreen Ingredient in Decades Read More
WASHINGTON, D.C. — The U.S. Department of Energy plans to provide up to $500 million in Defense Production Act funding to support 13 coal-related projects, including upgrades at existing coal-fired …
DOE Directs $500 Million Toward Coal Plants, Export Hub Read More
WILMINGTON, DE — AstraZeneca has secured U.S. regulatory approval for IMFINZI (durvalumab) in combination with Bacillus Calmette-Guérin (BCG) therapy for adults with previously untreated high-risk non-muscle-invasive bladder cancer, expanding the …
AstraZeneca Wins FDA Approval for IMFINZI in Early Bladder Cancer Read More WASHINGTON, D.C. — The U.S. Food and Drug Administration has released draft guidance that could shorten development timelines for gene therapies by allowing drugmakers to make greater use of existing …
FDA Issues Gene Therapy Guidance Aimed at Faster Reviews Read More
HORSHAM, PA — The U.S. Food and Drug Administration has approved a label expansion for Johnson & Johnson’s (NYSE: JNJ) TREMFYA, allowing the company to market clinical evidence showing the …
FDA Expands TREMFYA Label to Include Joint Damage Data in Psoriatic Arthritis Read More WILMINGTON, DE — AstraZeneca and Daiichi Sankyo have secured U.S. approval for DATROWAY as a first-line treatment for certain patients with metastatic triple-negative breast cancer, expanding treatment options in a …
AstraZeneca, Daiichi Sankyo Win FDA Approval for DATROWAY in Breast Cancer Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has proposed reducing animal testing requirements for certain cancer therapies, a shift that could lower development costs and shorten preclinical timelines …
FDA Moves to Cut Animal Testing for Some Cancer Drugs Read More